Is Janumet 50/1000mg tablet is targeted therapy or chemotherapy?

Janumet 50/1000mg tablet is not a targeted therapy or chemotherapy, but it is a conventional medication used for the management of type 2 diabetes mellitus.

Can Janumet 50/1000mg tablet improve blood sugar level?

Janumet 50/1000mg tablet does not permanently cure high blood sugar levels. To manage sugar patient should use the tablet as directed by the healthcare professional.

Is Janumet 50/1000mg tablet cause any side effects?

Janumet 50/1000mg tablet shows common side effects; some patients may experience severe symptoms as well. Visit the doctor if the symptoms persist.

How to take Janumet 50/1000mg tablet?

Janumet 50/1000mg tablet dosage and duration should be taken based on the patient's medical history and the doctor prescription.

Buy Janumet 50/1000 mg Tablet Online: Price, 3% Discount, Uses, and Side Effects

Description

Janumet 50/1000mg tablet is an antidiabetic medicine used for treating type 2 diabetes mellitus. It contains two active ingredients: Sitagliptin (50mg) + Metformin (1000mg).

Sitagliptin (50mg) belongs to the group class of DPP-4 inhibitors and Metformin biguanide class belongs to the biguanide class. They help combine blood sugar levels in people with type 2 diabetes mellitus by improving insulin action and reducing glucose production in the body.

A doctor's prescription is required to ensure safe and effective treatment.

Uses

Control blood sugar in a diabetic patient.

Side Effects

Every medication shows various side effects. Janumet 50/1000mg tablet also causes various symptoms, some are mild, and some need proper medical attention to reduce the side effects. Reach out to a doctor if any of the symptoms persist or worsen:

Low blood sugar (Hypoglycaemia)
Lightheadedness
Dizziness
Anxiety
Nervousness
Tiredness
Feeling hungry
Visual disturbances
Headache
Shaking
Sweating
Pale skin
Skin rashes
Pain, redness, swelling at the injection site.

How To Use

Janumet 50/1000mg tablet should be taken with a meal to avoid stomach upset.
It should be taken twice daily at the fixed time every day to enhance the effectiveness of the medication.
Never self-administer the dose, and if you miss a dose, do not take a double dose to make up for the missed one.
Always follow the prescription-based medication to avoid complications during the treatment.

How It Works

Janumet 50/1000mg tablet works by decreasing glucose production in the liver, reducing absorption of glucose, and improving insulin sensitivity. Sitagliptin increases the level of incretin hormones that help the pancreas release more insulin after meals and reduce the amount of glucose produced by the liver.

Together, they improve blood sugar more effectively than either medication alone.

Safety Advice

Alcohol

Avoid alcohol due to the risk of lactic acidosis, a rare but serious side effect while using Janumet 50/1000mg tablet. Discuss the safe limits with the doctor.

Pregnancy

Pregnant women should avoid using Janumet tablet as it may affect the newborn baby. Follow the recommended dosage as directed by the healthcare professional.

Breast Feeding

Janumet tablet causes harm to the breastfeeding baby as the medicine can pass through the breast milk.

Driving

Janumet tablet does not usually affect alertness. Do not drive if you experience low blood sugar. For more information, consult with the healthcare professional

Kidney

Kidney patients should consult with a healthcare professional before taking the Janumet 50mg tablet to ensure safety.

Liver

Liver patients should avoid taking the Janumet 50mg tablet as the medicine interferes with kidney function.

FAQs

Janumet 50/1000mg tablet manages type 2 diabetic mellitus in patients.

Use it on a regular basis for better efficacy.

Referencess

Bhagyasri, A., Raja, I., Panwar, B., Duggani, M., Nagalla, B., Prabhu, M. U., & Kaktikar, S. Digital Nutrition Counseling and its Impact on Diabetics and Prediabetic Individuals in the Developing Country. https://www.informaticsjournals.co.in/index.php/fijrfn/citationstylelanguage/get/apa?submissionId=44790&publicationId=46187
Akhtar, J., Khan, M. I., Parveen, S., & Ahmad, A. An update on fixed‐dose combination of SGLT‐2 and DPP‐4 inhibitors in the management of type‐2 diabetes. https://www.researchgate.net/publication/372892117_An_Update_On_Fixed-Dose_Combination_Of_Sglt-2_And_Dpp-4_Inhibitors_In_The_Management_Of_Type-2_Diabetes_Section_A-Research_paper_Eur
Wavrin, A. M. (2019). Risks and Benefits of Statin Use When at Target Goal. https://pmc.ncbi.nlm.nih.gov/articles/PMC10892755/
Hantash, A. A., Safieh, M. A., Iriqat, S., & Daraghmeh, M. (2021). Bilateral Abducens Nerve Palsy and the possible Association with COVID-19: A Case Report. J. Archives of Medical Case Reports and Case Study, 4(4). https://auctoresonline.org/article/bilateral-abducens-nerve-palsy-and-the-possible-association-with-covid-19-a-case-report https://auctoresonline.org/article/bilateral-abducens-nerve-palsy-and-the-possible-association-with-covid-19-a-case-report
Gowan, J., & Roller, L. (2016). Disease state management: Diabetes type 2: Improving control by working collaboratively. AJP: The Australian Journal of Pharmacy, 97(1152), 78-86. https://ajp.com.au/cpd/disease-state-management/ https://ajp.com.au/cpd/disease-state-management/

Janumet 50/1000 mg Tablet

About The Product